Sugi Predict
/ Targets
/ RPS24
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to RPS24 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris |
PHASE4 | UNKNOWN |
| Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea |
PHASE3 | COMPLETED |
| Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients |
PHASE2 | COMPLETED |
| Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer |
PHASE1/PHASE2 | COMPLETED |
| Effects of Vitamin D Supplementation on Muscle Protein Synthesis |
PHASE2 | COMPLETED |
| Everolimus for Children With Recurrent or Progressive Ependymoma |
PHASE2 | COMPLETED |
| Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI |
PHASE2 | COMPLETED |
| ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma |
PHASE2 | COMPLETED |
| Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC |
PHASE2 | COMPLETED |
| Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma |
PHASE1 | COMPLETED |
| Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia |
PHASE1 | RECRUITING |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
PHASE1 | WITHDRAWN |
| A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection |
PHASE1 | COMPLETED |
| A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors |
PHASE1 | COMPLETED |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery |
PHASE1 | COMPLETED |
| Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients |
PHASE1 | UNKNOWN |
| Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus |
EARLY_PHASE1 | COMPLETED |
| Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) |
nan | RECRUITING |
| Effect of Branched Chain Amino Acids on Muscle |
nan | COMPLETED |
| Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma |
nan | COMPLETED |
| Role of Sorcin and Annexin A3 in Breast Cancer Patients |
nan | UNKNOWN |
| Testing of Micellar Casein, Blended Micellar Casein and Native Whey |
nan | COMPLETED |
| Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) |
nan | COMPLETED |
| miR-155 Expression in Episodic and Chronic Migraine |
nan | UNKNOWN |
| Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus |
nan | COMPLETED |
| MicroRNAs and Cytokines in Peri-Implantitis Tissue |
nan | UNKNOWN |
| Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases |
nan | UNKNOWN |
| Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation |
nan | COMPLETED |
| Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas |
nan | ACTIVE_NOT_RECRUITING |
| Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a RPS24 binder may also engage these)